Nested Case Control, Age: 40-84 years, W, Breast cancer patients Age, sex, > 30 vs 21-24.9 0.98 (0.79-1.23) Recurrence, baseline kg/m2 colon cancer, performance > 30 vs 21-24.9 men status, bowel 1.11 (0.94-1.30) kg/m2 obstruction, ethnicity/race, Intergroup bowel Meyerhardt, 0089, perforation, 2003 Historical Measured by completion of 3 438 Hospital Recurrence COL00898 Cohort, clinicians chemotherapy, 9 years USA Age: 62.00years, duke stage of Recurrence, >3 0 vs 21-24.9 M/W disease, colon cancer, 1.24 (0.98-1.59) kg/m2 predominant women macroscopic pathologic feature, presence of peritoneal implants Wong, 2003 SCHS, 217/ Incidence, 28 vs < 22 ≥ COL00586 Nested Case Cancer registry Self-reported No RR available 63 257 colorectal cancer kg/m2 Control,
Nested Case Control, Age: 40-84 years, W, Breast cancer patients Meyerhardt, 2003 COL00898 USA Intergroup 0089, Historical Cohort, Age: 62.00years, M/W 3 438 9 years Hospital Measured by clinicians Recurrence, colon cancer, men > 30 vs 21-24.9 kg/m2 0.98 (0.79-1.23) Age, sex, baseline performance status, bowel obstruction, ethnicity/race, bowel perforation, completion of chemotherapy, duke stage of disease, predominant macroscopic pathologic feature, presence of peritoneal implants Recurrence > 30 vs 21-24.9 kg/m2 1.11 (0.94-1.30) Recurrence, colon cancer, women >3 0 vs 21-24.9 kg/m2 1.24 (0.98-1.59) Wong, 2003 COL00586 SCHS, Nested Case Control, 217/ 63 257 Cancer registry Self-reported Incidence, colorectal cancer ≥ 28 vs < 22 kg/m2 No RR available
CUP_colorectal_SLR_2016_RO.docx